Abstract
Postoperative cognitive dysfunction (POCD) describes a decline in cognitive function for weeks or months after surgery with a prevalence in the elderly patient. Numerous methodological limitations make the interpretation of this clinical syndrome, based on the available literature on POCD, difficult, particularly the different definitions of POCD, the lack of control groups and the relative inconsistency in the occurrence of memory deficits. Several theories have been advanced to explain these observations, but although there is general agreement that POCD is likely to be multifactorial, whether its occurrence is a result of the effects of surgery or general anesthesia remains unclear. This review provides a synopsis of the available clinical and preclinical data and summarizes recent research relevant to the occurrence of POCD and possible pharmacologic algorithms for its prevention and treatment. The effects of volatile and intravenous anesthetics on synaptic transmission and synaptic plasticity, which might be related to cognitive dysfunction in the postoperative period, will be discussed. Unraveling these mechanisms should provide helpful indices for the identification, synthesis and development of new chemical entities suitable for therapeutic use.
Central Nervous System Agents in Medicinal Chemistry
Title: Anesthesia and Postoperative Cognitive Dysfunction (POCD)
Volume: 8 Issue: 1
Author(s): Gerhard Rammes, Bettina Jungwirth, Walter Zieglgansberger and Eberhard Kochs
Affiliation:
Abstract: Postoperative cognitive dysfunction (POCD) describes a decline in cognitive function for weeks or months after surgery with a prevalence in the elderly patient. Numerous methodological limitations make the interpretation of this clinical syndrome, based on the available literature on POCD, difficult, particularly the different definitions of POCD, the lack of control groups and the relative inconsistency in the occurrence of memory deficits. Several theories have been advanced to explain these observations, but although there is general agreement that POCD is likely to be multifactorial, whether its occurrence is a result of the effects of surgery or general anesthesia remains unclear. This review provides a synopsis of the available clinical and preclinical data and summarizes recent research relevant to the occurrence of POCD and possible pharmacologic algorithms for its prevention and treatment. The effects of volatile and intravenous anesthetics on synaptic transmission and synaptic plasticity, which might be related to cognitive dysfunction in the postoperative period, will be discussed. Unraveling these mechanisms should provide helpful indices for the identification, synthesis and development of new chemical entities suitable for therapeutic use.
Export Options
About this article
Cite this article as:
Rammes Gerhard, Jungwirth Bettina, Zieglgansberger Walter and Kochs Eberhard, Anesthesia and Postoperative Cognitive Dysfunction (POCD), Central Nervous System Agents in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/187152408783790622
DOI https://dx.doi.org/10.2174/187152408783790622 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Insights into the Role of HIF-1 in Cutaneous Wound Healing
Current Molecular Medicine The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
Current Medicinal Chemistry The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Using Simulation in Clinical Education: Psoriasis Area and Severity Index (PASI) Score Assessment
Current Rheumatology Reviews The Role of Adipocytokines and Neurohormonal Dysregulation in Metabolic Syndrome
Current Diabetes Reviews Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
CNS & Neurological Disorders - Drug Targets Pindolol Augmentation of Antidepressant Response
Current Drug Targets MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Animal Models of Carcinogenesis in Inflamed Colorectum: Potential Use in Chemoprevention Study
Current Drug Targets Review of Trans-Atlantic Cardiovascular Best Medical Therapy Guidelines – Recommendations for Asymptomatic Carotid Atherosclerosis
Current Vascular Pharmacology Metabolomics for Personalized Nutrition Research and Clinical Applications
Current Pharmacogenomics and Personalized Medicine Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets Foreword:
Current Pharmaceutical Design Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy
Current Medicinal Chemistry Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Blood Pressure Variability and Mortality in end Stage Renal Disease
Current Hypertension Reviews Short Term, Low Dose Simvastatin Pretreatment Alters Memory Immune Function Following Secondary Staphylococcus aureus Infection
Current Pharmaceutical Biotechnology Hypothyroidism and Nephrotic Syndrome: Why, When and How to Treat
Current Vascular Pharmacology